Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pubertal replacement therapy in boys: low-dose Testoviron Depot vs Nebido with rhFSH
2012-002337-11Phase 2Completed
- Sponsor
- Region Västra Götaland
- Start
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in delayed puberty comparing rhFSH + low-dose Testoviron Depot with rhFSH + low-dose Nebido (2 arms). Primary endpoints: Serum testosterone levels during treatment, LH increase after GnRH test in group I and 1 more. Started Jun 2012; status: completed.
02
Drugs
testosterone propionate + testosterone enanthatetestosterone undecanoaterecombinant human follicle stimulating hormone
03
Conditions
delayed puberty
Beyond the preview
Go deeper on 2012-002337-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002337-11.